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1. Introduction 
Head and Neck Squamous Cell Carcinoma (HNSCC) is the sixth most prevalent neoplasm 
in the world, with approximately 900,000 cases diagnosed worldwide (Chin, Boyle et al. 
2006). The chronic use of tobacco and alcohol consumption has long been recognized as 
prominent risk factors in the development of oral cancer (Hashibe, Brennan et al. 2009). Oral 
Cancer is the 8th and 13th most common malignancy in the world for males and females 
respectively. Up to 80 % of these cancers occur in Asia (Cheong, Chandramouli et al. 2009). 
Precancerous and cancerous oral lesions may mimic any number of benign oral lesions, and 
as such may be left without investigation and treatment until well advanced.  
The five year survival following the diagnosis of oral malignancy can be as low as 15-50% as 
most cancer are advanced and associated with lymphatic spread at the time of discovery 
(McCullough and Farah 2008). Most patients with oral cancer or a potentially malignant  
oral mucosal lesion are often asymptomatic at the time of diagnosis (Baranovsky and Myers 
1986). Some patients do not seek care until pain, persistent ulceration, unexplained bleeding 
or an oral or neck mass is discovered at which time the disease is very advanced.  
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Most cancer deaths occur in patients 55 years or older (Silverman and Gorsky 1990). Thus, 
oral cancer is predominantly a disease of the elderly and for those with known 
epidemiologic risk factors, sufficient time exists to examine patients, detect precursor lesions 
and treat prior to the development of malignancy.  
2. Aetiology 
There are several known risk factors in the development of oral cancer with the most 
studied and well-established being the use of tobacco (Marder 1998; Hashibe, Brennan et al. 
2009). In the developing world, tobacco and areca nut use, either alone or in combination, 
account for the majority of leukoplakias, whereas the majority of oral leukoplakias in the 
developed world are associated with just the use of tobacco (Napier and Speight 2008). 
Heavy smokers have been shown to be seven times more likely than non-smokers to have 
leukoplakias. Further, the importance of tobacco is reinforced by the regression and ⁄ or 
disappearance of many lesions following cessation with a recent study showing that 56% 
regressed at 3 months and 78% regressed a year after smoking cessation (Napier and 
Speight 2008). 
2.1 Alcohol 
There is increasing evidence of the role of alcohol consumption in the development of oral 
cancer (Hindle, Downer et al. 2000; Hashibe, Brennan et al. 2009). In a recent large pooled 
study undertaken by the International Head and Neck Cancer Epidemiology (INHANCE) 
consortium, analyzed 11,221 patients with head and neck cancer and 16,168 controls and 
showed a greater than multiplicative joint effect of both tobacco and alcohol (Hashibe, 
Brennan et al. 2009). Further, this study estimated the population attributable risks for 
smoking and drinking combined to be 64% (95% CI: 45-75%) showing that the joint effect 
of tobacco and alcohol is responsible for a large proportion of head and neck cancers 
(Hashibe, Brennan et al. 2009). Interestingly though, this study also concluded that a 
proportion of head and neck cancers cannot be attributed to either tobacco or alcohol, 
particularly for oral cavity cancer, among women and below age 45 (Hashibe, Brennan et 
al. 2009). 
The ability of alcohol to cause protein denaturation and lipid dissolution, as well as its 
anti-microbial activity against most bacteria, fungi and viruses has resulted in alcohol 
being used in mouthwashes as a solvent, preservative and antiseptic agent. Studies have 
shown that high concentrations of alcohol in mouthwashes may have detrimental oral 
effects such as epithelial detachment, keratosis, mucosal ulceration, gingivitis, petechiae, 
and oral pain (Hsu TC, Furlong C et al. 1991; Warnakulasuriya S, Parkkila S et al. 2008) 
Furthermore, there is increasing evidence that there may be a direct relationship between 
the alcohol content of mouthwashes and the development of oral cancer, specifically, an 
increased risk of acquiring cancer (oral cavity, pharynx, larynx) by over 9 times for 
current smokers, over 5 times for those who also drink alcohol, and almost 5 times for 
those who neither smoke nor drink alcohol (Guha, Boffetta et al. 2007). A recent review of 
the literature suggested that it would be inadvisable for oral health care professionals to 
recommend the long-term use of alcohol-containing mouthwashes (McCullough and 
Farah 2008). 
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While alcohol was initially described as only a risk enhancer in smokers, there is now 
sufficient epidemiological evidence to suggest that chronic alcohol consumption is an 
independent risk factor (Rothman and Keller 1972; Herity, Moriarty et al. 1981; Maserejian, 
Joshipura et al. 2006). The exact mechanism of alcohol on the development of oral cancer 
remains unclear, as alcohol in itself is not clastogenic, mutagenic or carcinogenic. There is 
growing evidence that the local oxidation of alcohol to its toxic metabolite, acetaldehyde 
(AA), may be the ultimate mechanism for mediating the carcinogenic effect of alcohol in the 
mouth (Seitz, Matsuzaki et al. 2001).  
AA is the first metabolite of alcohol and is a well-known mutagenic and carcinogenic agent 
(Feron, Kruysse et al. 1982). The 1999 International Agency for Research on Cancer 
Monographs evaluated the carcinogenic risk of AA and concluded that there was 
inadequate evidence in humans, but sufficient evidence in experimental animals of the 
carcinogenic nature of AA. Although the bulk of alcohol metabolism is carried out in the 
liver, extra-hepatic metabolism of alcohol to AA has been shown to occur elsewhere in the 
body including the oral cavity. An early study demonstrated considerable AA production in 
saliva (up to 143µM) after moderate consumption of alcohol (0.5g/kg body weight) 
(Homann, Karkkainen et al. 1997). The level of AA formed was well above endogenous AA 
level of 1µM (Lachenmeier, Kanteres et al. 2009) and was within the range that is capable of 
inducing mutagenic changes 50-150µM (Salaspuro 2007). Furthermore, studies have also 
found that ingested alcohol may in fact be metabolized to AA by commensal organisms in 
the oral cavity via microbial alcohol dehydrogenase. Microorganisms that have been 
documented to be significantly associated with higher AA production include Streptococcus 
spp., particularly S. Salivarius, Neisseria spp and Candida albicans (Homann, Tillonen et al. 
2000; Muto, Hitomi et al. 2000; Kurkivuori, Salaspuro et al. 2007). The known toxic effect of 
AA as well as its local production in the mouth has led to increasing interest in the level of 
salivary AA formed after alcohol-containing mouthwash use and its association with oral 
cancer development.  
Epidemiological studies have not led to a definitive consensus on the association of alcohol-
containing mouthwashes and oral cancer. Lachenmeier et al (2009) tested the salivary AA 
content of four healthy individuals after rinsing with alcohol-containing mouthwash 
(Lachenmeier, Gumbel-Mako et al. 2009). Using headspace gas chromatography, this study 
found salivary AA concentrations significantly above endogenous levels.  
To further our understanding of the level of salivary acetaldehyde after rinsing with alcohol 
containing liquids, we have recently completed an study with 30 healthy dentate dental 
students from the University of Melbourne participated in this study. They were selected 
based on the following criteria: 1) >18years of age; 2) good over-all health; 3) non-smoker; 4) 
non-intraoral prosthesis; 5) healthy dentition with no oral problems. The four test liquid 
samples selected were red wine (14% vol. alcohol), scotch whiskey (43% vol. alcohol), low 
alcohol mouthwash with chlorhexidene (11.5% vol. alcohol) and high alcohol mouthwash 
(26.9% vol. alcohol).  
Saliva samples for each test liquid were collected on different days. Participants were 
randomly allocated a test liquid depending on the day of sampling. Participants were 
excluded if they had consumed food or drink, or performed oral hygiene in the previous 2 
hours or consumed alcohol in the previous 24 hours.  
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Baseline salivary samples were collected before participants rinsed with any test liquid. 
Participants were then instructed to rinse 20ml of the selected test liquid vigorously for 30 
seconds and expectorate immediately. Salivary samples were collected after 1 and 5 minutes 
after the expectoration of test liquid. Patients were required to chew on cotton rolls for 1 
minute before sampling. The cotton rolls were centrifuged for 2 minutes at 3000 g in 
Salivette saliva collection tubes (Sarstedt, Australia Pty Ltd). A 450 µL sample of the clear 
saliva supernatant was then transferred to a 10 mL headspace vial containing 50 µL of 
perchloric acid (20% w/w) (Eriksson et al, 1982). The effect of sample storage conditions 
were tested by comparing AA concentrations in a set of spiked samples frozen for 2 days 
against a batch of freshly spiked samples.  
Salivary AA concentrations were measured using headspace gas chromatography similar to 
previously reported methods (Lachenmeier, Gumbel-Mako et al. 2009). A gas 
chromatograph (GC-2010, Shimadzu) equipped with a flame ionization detector (FID) and 
headspace autosampler (AOC-5000, CTC analytics) was used for analysis. Data acquisition 
and analysis were performed using GC Solutions software. Sample vials were first 
incubated for 5 min at 50oC in the autosampler’s oven to achieve a favourable vapour-liquid 
equilibrium of the AA in the headspace vials. Thereafter, 1 mL of sample headspace was 
automatically drawn into the injection syringe by means of the electropneumatic dosing 
system and injected into the GC using a split ratio of 10:1. The GC conditions used to 
separate the volatile components in the saliva were as follows: column: 30 m x 0.25 mm I.D. 
x 0.25 μm film thickness (DB-23, J&W Scientific Inc.); temperature program: 40oC hold for 2 
min, 80oC/min up to 200oC and hold for 3 min; injection port temperature: 200oC; FID 
temperature: 250oC; carrier gas (He) flow rate: 30 cm/sec.  
The suitability of the internal standards method, the calibration curve method and the 
standard addition method for calculating the unknown AA concentration in the saliva 
samples was studied. The results shown in Table 1 indicate that the analyte concentration 
detected from the saliva standards is in good correspondence to that with standards made 
up in deionized water. The calibration curve prepared from aqueous AA standards (1, 2, 5, 
10 mg/L) was linear over the whole range and the limit of detection was 0.5 mg/L (11.4µM). 
Preliminary experiments indicated that the method developed had good reproducibility 
(%RSD = 1.05%, n = 6). 
All mouthwashes caused a statistically significant (p < 0.05) increase in production of AA at 
both the 2 minutes and 5-minute samples when compared to the pre-mouthwash sample. 
Statistically significantly more AA was present at the 2-minute interval than at the 5-minute 
sample (Table 1). However, even 5 minutes after rinsing there was statistically significantly 
more AA present for all four mouthwashes when compared to the pre-mouthwash sample. 
There was no significant difference (p = 0.218) between the levels of AA produced 5 minutes 
after rinsing with any of the 4 solutions. 
There are of course limitations to this preliminary study in particular the small sample size 
with only nine subjects for each test liquid. Nevertheless, these results indicate that rinsing 
with alcohol produced an increase in oral AA above endogenous levels and in the range 
capable of inducing mutagenic change (50-150µM) and that alcohol containing mouthwash has 
a similar effect on acetaldyde levels within the oral cavity as recreational alcohol containing 
liquids. These results indicate that further investigation is required into the levels of AA 
produced by a wide range of alcohol containing liquids, particularly those in common use. 
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Alcohol 
(%) 
Average AA concentration (µM) 
Baseline  1 minute  5 minutes 
Scotch  43 8.1 ± 8.1 97.0 ± 33.2 41.9 ± 21.2 
Wine 14 11.2 ± 6.4 59.4 ± 31.0 33.8 ± 20.2 
Listerine  26.9 9.1 ± 5.9 53.5 ± 19.3 25.1 ± 11.6 
Savacol 11.5 18.5 ± 11.2 43.8 ± 13.8 31.4 ± 7.5 
Table 1. Average АА concentration after rinsing with test liquids. 
We have further assessed whether alcohol-containing mouthwashes (ACM) can induce 
cellular toxicity and/or genotoxicity in human cells in vitro with the single-cell gel (comet) 
assay and morphological assessment of apoptosis and mitosis, in order to clarify suggestive 
but inconclusive epidemiological data concerning a potential oral cancer risk associated 
with regular use of alcoholic mouthwash. Normal (OKF6/TERT-2 cells ) (Dickson MA 2000) 
and dysplastic (DOK cells) (Chang Se 1992) human oral epithelial cells were treated for 30 
seconds with a 1:5 alcohol-containing mouthwash (26% ethanol) dilution and equivalent 
concentration of ethanol (5.4%) for comparison. The negative control group was treated with 
phosphate buffered saline solution and the positive control group was treated with 650µM 
H2O2. Recovery time points of 5, 10 and 20 minutes were allowed before trypsinisation and 
layering onto slides with low-melting point agarose for electrophoresis. DNA damage was 
scored using the visual method established by Speit and Hartmann (Speit G 2006). 
Parameters from the comet assays and cytotoxicity testing were analysed by one-way 
ANOVA and Tukey’s test. 
ACM and ethanol treatment groups consistently demonstrated significantly greater DNA 
damage (P < 0.001) in the comet assay when compared to negative controls. No significant 
difference was noted between recovery time points. No significant differences in apoptosis 
and mitosis were noted between treatments and controls in the cytotoxicity assay, however 
OKF-6 cells (normal) were shown to have increased apoptosis and decreased mitosis when 
compared to DOK cells (dysplastic). These results indicate that ACMs do have a genotoxic 
effect in oral epithelial cells, however they do not induce cellular toxicity in these short-term 
laboratory conditions. 
Although separate assays exist to detect damage through each specific mechanism discussed 
above, the comet assay is a general test for detection of DNA breakage- the end result of all 
damage pathways. It is sensitive to DNA single- and double-strand breaks, interstrand 
cross-links, and apurinic/apyrimidinic (AP) sites which relax the supercoiled structure of 
genomic DNA under alkaline conditions (Speit G 2006). Multiple studies have established 
that visual scoring is both efficient and accurate, bearing a linear correlation to computer 
scoring (Garcia O 2004) (Panayiotidis MI 2004). Results indicate that ACMs cause significant 
fragmentation of DNA, which over many cycles can lead to mutation. Furthermore, it was 
found that no DNA repair occurred within the 20 minutes allowed for recovery following 
treatments, allowing carcinogenic effects to compound more rapidly. 
Selecting two cell lines (DOK and OKF-6) for experiments permitted testing of ACM effects 
on normal oral epithelial cells, as well as allowing comparisons to be made with dysplastic 
cells. Results from the comet assay indicate that DNA damage is significantly greater in 
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DOK cells compared to OKF-6 cells, supporting the idea that ACM use may be a greater risk 
in smokers or patients with pre-existing dysplasia. Previous research shows that risk 
associated with alcohol consumption is not necessarily constant over the multistage 
pathway to oral cancer (Franceschi S 2000) (Franceschi et al., 2000). Traditionally, alcohol has 
been thought to play a role in the later stages of oral cancer progression (Day & Brown, 
1980), a view supported by our results. However newer studies are finding that drinking 
may exert earlier effects, as cessation does not lower oral cancer risk for up to 9 years 
(Franceschi S 2000) Temporal mechanisms of alcohol carcinogenicity may be more complex 
and multifactorial than previously thought. Although experiments used were not sensitive 
to a concurrent synergism between ACM and tobacco carcinogens, it was possible to 
ascertain the possibility of a sequential synergistic effect with tobacco because DOK cells 
were developed from the tongue mucosa of a smoker.  
Thus, it would appear that the effect of alcohol consumption on oral epithelial cells is likely 
to be local, topical and temporally important in oral carcinogenesis. 
2.2 Human Papilloma Virus 
For many years, HPV has been accepted as an important cofactor in the development of 
cervical cancer, originating from a mucous membrane with similarities to the oral mucosa. It 
has long been postulated that oncogenic HPV subtypes (specifically, HPV 16 and 18) can 
have a tumorigenic effect on oral epithelia. Evidence to support a role for HPV was found in 
analysis of the presence of HPV in biopsy specimens, the majority concluding that it was 
likely that HPV may be a cofactor in the development of oral cancer (Nielsen, Norrild et al. 
1996; D'Costa, Saranath et al. 1998; Al-Bakkal, Ficarra et al. 1999). The INHANCE 
consortium mentioned above reported on the analysis of a large cohort assessing links 
between cancer and specific sexual behaviours, including practice of oral sex, number of 
lifetime sexual partners and oral sex partners, age at sexual debut, a history of same-sex 
contact and a history of oral-anal contact. This study concluded that these sexual behaviours 
are associated with increased risk of cancer, particularly of the tongue, tonsil and oro-
pharynx and reinforce the association with infection by HPV sub-types (Heck, Berthiller et 
al. 2009). Furthermore, it has been shown that there is an overall increase in the incidence of 
base of tongue cancer over the past 30 years and further that there is an increase in the 
prevalence of HPV in these tongue cancers (Attner, Du et al. 2009). Thus, it would appear 
that there is an increased understanding of the causative role for HPV in oral and oro-
pharyngeal cancer with an urgent need for further research in the role of that this virus may 
play in the propagation of potentially malignant mucosal lesions. 
A recent extensive collaborative study recently reported the prevalence of HPV types in the 
oropharynx in men who have sex with men (MSM) and compared sampling methods as 
well as identifying risk factors. This cross-sectional study enrolled 250 HIV negative and 250 
HIV positive MSM who were sampled by either a self-collected flocked throat/mouth swab 
agitated in RNAlater or collected gargled saline. Further, a questionnaire about sexual 
behaviour, oral hygiene and smoking was collected. 
HPV PCR was undertaken after DNA extraction using MagNA Pure LC (Roche Molecular 
Systems) the HPV DNA amplification was undertaken using L1 consensus primers & beta-
globin control via PCR. An ELISA using biotin-labeled probe was used to identify PCR 
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products and subsequently a line-blot hybridization (Linear array - Roche) used to genotype 
the PCR product. 
The results of this study showed a prevalence of oral HPV with 74 positive in one or both 
samples. The self-collected flocked throat and mouth swab was positive in 33 of the 74 
(44.6% sensitive) while the oral rinse was positive in 65 of the 74 positive samples (87.8% 
sensitive). High-risk genotypes (16 and 59) were found in 21 (4.2%) samples. The HPV 
prevalence in this MSM population depended on the HIV status with those HIV negative 
showed 8% (0.8% HPV 16) positive samples while those MSM who were HIV positive had 
22% (4.8% HPV 16) positive samples. Oral rinse method of sample collection was nearly 
twice as sensitive as self-collected swab. Significant risk factors included smoking, age 
greater than 40 and lifetime oral sex partners greater that 100. 
Thus, it would appear that high-risk HPV sub-types are present in the oral cavity, and this 
presence is associated with risk behaviours, in particular smoking and the number of 
lifetime oral sex partners. It could be postulated that there is synergism of these risk 
factors, particularly if alcohol consumption was also included. There is therefore a need 
for the development and clinical validation of a simple salivary method for the 
assessment of risk of developing oral cancer that is not associated with smoking as this is 
likely to enhance the effectiveness of oral cancer screening services and improving oral 
cancer outcomes.  
3. Novel biomarkers 
Currently the gold standard in diagnosis of malignant and potentially malignant oral 
mucosal lesions is incisional biopsy and histo-pathological assessment. However, 
histopathological examination has concerns related to sampling errors and errors in 
interpretation, and lacks sensitivity to determine lesion progression.(Holmstrup, Vedtofte et 
al. 2006) That is, the level of dysplasia of an oral lesion may not necessarily correlate with 
the lesion’s potential for malignant transformation. Hence, there is a need for a more 
accurate system to predict the progression to cancer and currently there is significant work 
being undertaken in identifying markers in patients with oral cancer and pre-cancer that 
may serve as a valuable resource in finding markers for the early diagnosis of these 
conditions. 
3.1 DNA ploidy 
Several studies have already shown that DNA ploidy is of prognostic importance in some 
human malignancies such as carcinomas of the ovary (Brescia and et al. 1990), prostate 
(Badalament and et al. 1991), urinary bladder (Norming and et al. 1992) and malignant 
melanomas (Sorensen and et al. 1991). Importantly, DNA ploidy has been shown to be an 
early marker of malignant transformation in oral dysplasia (Sudbo and et al. 2001). DNA 
ploidy can be classified into three clinically relevant categories, diploid, tetraploid and 
aneuploid. The positive correlation that has been reported to exist between DNA ploidy and 
prognosis of oral dysplasia (Sudbo and et al. 2001), suggests that DNA ploidy may well be a 
key factor in the diagnosis, prognosis and treatment of oral malignancies in the future and 
thus requires full investigation. 
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The use of DNA ploidy for oral mucosal conditions has attracted considerable controversy 
(Curfman GD 2006; Reed KD 2007). There was considerable promise in the early part of 
this decade that the use of DNA ploidy could better predict outcome for potentially 
malignant oral mucosal disease. Irrespective of the controversies associated with a large 
portion of this work multiple independent and meticulous studies have been undertaken 
to attempt to put the investigations of the utility of oral mucosal DNA ploidy on a sound 
scientific basis. Interestingly, the results of these studies have been varied with some 
reporting guarded success at predicting outcome of malignant transformation (Torres-
Rendon and et al. 2009 June), while others have shown little benefit from this technique in 
assessing the malignant potential of mucosal lesions (Neppelberg and Johannessen A.C. 
2007). 
The majority of previous studies assessing DNA ploidy in oral mucosal lesions have used 
nuclei isolated from formalin fixed, paraffin embedded, archival material 19-22. These nuclei 
were extracted, processed to form a monolayer on glass slides and, after Feulgen staining, 
individual nuclei selected for integrated optical density analysis. The number of nuclei 
analyzed was usually in the range of 200-300 per sample 22. In each of these retrospective 
studies, internal control nuclei within each monolayer, such as inflammatory cells or 
“unsuspicious” epithelial cells, were used to assess for significant variations from DNA 
diploidy (aneuploidy) of nuclei from each specimen. However, as a prospective clinical tool, 
such methodology is limited.  
Over recent years there has been increased use of liquid-based cytology (LBC) for cervical 
smears and this method has been analyzed for utility with oral cytology (Kujan and et al. 
2006). The initial study evaluating LBC for oral cytology assessed 150 specimens from 50 
healthy volunteers and found that this technique distributed cells evenly, optimized 
fixation, improved and unbiased sampling, enhanced nuclear detail and eliminated air-
drying artifacts. These researchers also reported that the specimens showed cells from two 
populations, superficial and intermediate cells with only six (4%) of specimens containing 
parabasal or basal cells (Kujan and et al. 2006). This latter finding has significant impact as 
these superficial cells represent keratinocytes that are terminally differentiating and thus 
nuclei have become non-functional with condensed and fragmented chromatin.  
In a recent study (McCullough MJ 2009) assessing the variability of ploidy present in oral 
cytological material using nuclear analyses of integrated density via Feulgen staining, liquid 
based processing of oral cytological samples and the establishment of a large database of 
normality. This study found that there was more variabilitiy observed in patients with 
normal mucosa than in oral mucosal dysplasia and neoplasia. It may well be that these 
nuclear alterations present in the superficial cell layers resulted in increased optical 
integrated density after Feulgen staining observed and the observed lack of differentiation 
between normal and abnormal samples was likely to be due to sampling, with inadequate 
numbers of basal cells whose DNA could not be assessed separately from the large number 
of superficial nuclei (McCullough MJ 2009).  
An attempt to circumvent this tissue-sampling problem has been reported by obtained 
representative tissue specimens by scraping with a dermatological curette (Navone R 2008), 
thus producing “micro-biopsies” rather than cytological samples from brushing mucosa. 
Such a technique, which included liquid cytology for tissue handling, has been reported to 
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be a non-invasive, rapid method that has little patient discomfort and is able to sample a 
broader area than a single biopsy (Navone R 2008). Ideally, the analyses of the cells collected 
would include multiple markers, not only assessing the presence of basal cells in the sample, 
but also the extent of a number of genetic changes known to be linked to the development of 
oral neoplasia. This is unlikely to be feasible using ploidy assessment via the Feulgen 
reaction as this reaction requires acid hydrolysis of DNA significantly altering both 
cytological and nuclear attributes. Such markers may well include the recently reported 
centrosomal abnormalities reportedly to occur universally in oral dysplasia. 
Thus, there still remains the need for a robust method to assess molecular changes known to 
be associated with the early changes in neogenesis to aid in the early detection of oral 
mucosal lesions with increased malignant potential. 
3.2 mRNAs 
The identification of tissue markers that aid assessment of malignant potential have been 
investigated, and reviewed by Scully (Scully 1993). Such markers include cell surface and 
cytoplasmic components. 
Loss of Heterozygosity (LOH) is considered loss of genetic material at microsatellite loci, 
and has been shown to be an important event in tumorigenesis (Ng IO, Xiao L et al. 2000). 
Investigations of LOH in genes and chromosomal regions, has shown that defined regions 
are affected in oral carcinogenesis/HNSCC and that these may be used as a possible 
prognostic marker. 
A model for HNSCC progression has been proposed suggesting deletions at 3q, 9q and 17q 
are associated with a morphological transition of cells from normal to dysplastic cells, and 
that carcinoma development was promoted by further deletions at 4q, 6p, 11q, 13q and 14q 
(Califano J, van der Riet P et al. 1996). 
Single nucleotide polymorphisms (SNPs) are single base alteration or point mutations in 
DNA and are considered the most common form of genetic variation, occurring 
approximately every 1200 base pairs in human chromosomes (Sherry 2001). Hence, many 
studies have investigated the incidence of SNPs in particular genes to determine their role in 
HNSCC carcinogenesis. 
TP53 is an extensively characterised TSG, which encodes the protein p53. TP53 is located on 
the short arm of chromosome 17 and has 11 exons, one of which is non functional (Liao PH, 
Chang YC et al. 2000). p53 is a sequence specific transcription factor that is important for 
DNA maintenance.  
A study of 94 oral squamous cell carcinomas (OSSC) found that 43% had TP53 mutations 
(Ostwald, 2000), similarly another study observed 48.66% of OSSC had p53 mutations 
(Hsieh, Wang et al. 2001). An analysis of 18 oral tumours found 72% had TP53 mutation, 
however this high incidence may have been due to the small sample size (Partridge, 2000). 
Generally, TP53 mutations are considered a common genetic change, being evident in 40-
50% of HNSCC (Nylander, 2000). 
Other studies have documented associations between TP53 polymorphisms and HNSCC. 
One investigation observed the highest number of mutations occurred in exon 7 and that the 
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type of SNP was characteristic of lesion location. Lip lesions exhibited G:C to A:T transitions 
while intra-oral lesions exhibited an equal frequency of transitions and transversions (G:C to 
T:A) (Ostwald C, Gogacz P et al. 2000). It has been proposed that these transversions are 
preferentially induced by breakdown products of benz[a]pyrenes, suggesting a strong 
correlation with tobacco usage (Ostwald C, Gogacz P et al. 2000). A study of sequential 
epithelial dysplasias and squamous cell carcinomas suggested TP53 mutations correlated 
with an invasive tumour phenotype (Shahnavaz SA, Regezi JA et al. 2000). A further study 
reported greater than 90% of HNSCC samples had TP53 mutations, with the type of 
mutation varying among tumours (van Oijen MG, Vd et al. 2000 Feb ). They also 
demonstrated primary tumours and metastases showed the same TP53 mutation, 
suggesting that TP53 mutations are relatively stable within a given tumour. 
SNPs in other genes have been investigated including the CYP1A1 polymorphism in the 
gene encoding cytochrome p450. This polymorphism results in an amino acid substitution 
from Isoleucine to Valine. It has been proposed that the Valine form of the enzyme has a 
greater catalytic and mutagenic activity towards benz[a]pyrenes and therefore may be 
associated with high risk of OSSC development (Sato M, Sato T et al. 2000; Sreelekha TT, 
Ramadas K et al. 2001). However, other studies have not observed an association between 
this polymorphism and HNSCC (McWilliams JE, Evans AJ et al. 2000).  
3.3 MicroRNAs 
An area of interest for markers of potentially malignant mucosal lesions is MicroRNAs 
(miRNAs). MiRNAs are small non coding RNAs that mediate gene expression at the post-
transcriptional level by degrading or repressing target messenger RNAs (mRNAs). They act 
by binding to partially complementary sites in the 3` region of the mRNA target. MiRNAs 
are approximately 18 - 22 nucleotides in length and are predicted to regulate at least 30% of 
the mRNA transcripts (Gomes and Gomez 2008).  
MiRNAs are transcribed by RNA polymerase II or III as an independent gene unit or as 
part of an intron on a larger mRNA molecule. This mRNA can be up to 1000 nucleotides 
in length and has a stem-loop structure. This initial transcript is cleaved into a shorter 
stem-loop structure of less than 100 nucleotides by a type III RNAse (Drosha). This pre – 
miRNA is exported out into the cytoplasm by exportin-5 where another RNAse III (Dicer) 
cleaves it, resulting in a 18 – 24 nucleotide long mature miRNA. The mature miRNA is 
bound to a protein complex called an RNA induced silencing complex (RISC – RNA) 
formed by four argonaute family proteins (Ago 1-4). This active miRNA – protein 
complex binds to specific sites present in a number of mRNA’s resulting in their 
inactivation. To date, 1048 different human miRNAs have been identified in the miRBase 
database It has been shown that each mirNA regulates a number of mRNAs(Gomes and 
Gomez 2008).  
MicroRNAs bind to the 3’ untranslated region (30 UTR) of target mRNA. Depending on the 
degree of sequence complementary, the mRNA is either inhibited or degraded. Studies 
conducted up to date suggest that miRNAs function either as oncogenes or tumor 
suppressors in various cancer types, as well as OSCC. 
MiRNAs have been associated with almost all types of human malignancies including 
haematological and solid cancers. When the classification accuracy of types of cancer were 
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compared, variation from the normal profile of miRNAs were shown to more pronounced 
in poorly differentiated tumors (Hui, Shi et al. 2009). 
A reduction in miRNAs that suppress tumours is thought to result in an increase of 
oncogenic proteins and hence accelerates oncogenic transformation. On the other hand, an 
increase in miRNAs during oncogenises may be associated with inactivation of tumour 
suppressor genes thus accelerating oncogenic transformation as outlined in Fig.1. (Gomes 
and Gomez 2008). 
 
 
 
Fig. 1.  
Abnormal regulation of these miRNAs in OSCC induces cell proliferation and anti-
apoptosis, promotes cancer metastasis and potentiates resistance to chemotherapy. miRNA-
regulated pathways in OSCC (Bo-hai Wua, Xue-peng Xiong et al. 2011). 
In the past, a great deal of focus has been placed on messenger RNAs (mRNAs) and their 
ability to act as biological markers in cancer. Recent studies have shown that miRNAs more 
accurately cluster different types of solid tumors than mRNA, suggesting that miRNAs may 
be an alternative early marker of malignancy (J, G et al. 2005) Furthermore, the extent of 
change in mRNA between cancer cells and normal cells is relatively small, whereas, many 
miRNAs exhibit large changes between normal and cancer cells (in the order of ten to 
hundred fold changes) hence potentially enhancing detection of differences.(Jinmai Jiang, 
Eun Joo Lee et al. 2005) 
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It has been reported that miRNAs may be less prone to degradation and modification than 
mRNAs due to their small size, hence allowing the use of formalin fixed paraffin embedded 
(FFPE) samples (Martina, Magotra Amber A. et al. 2008). There is thus a potential rich 
source of retrospective information available for comparative genomics and investigation of 
potential biomarkers that is likely to provide biological insights far more expeditiously than 
the prospective collection of frozen samples.  
Abnormal miRNA expression has been found in both premalignant and malignant cells 
(Clague j, Scott M. Lippman et al. 2010). Hence, there is a need for the investigation of 
miRNA expression in potentially malignant oral mucosal lesions as well as OSCC as 
deregulated miRNAs may be an early reliable marker for malignancy as well as a potential 
target for cancer prevention. Although there are no specific patterns of miRNA expression 
till date, certain core miRNAs should be considered in tumorigenesis of the head and neck 
region. This core set includes, mir -21, mir -205 and mir – 155 which have shown to be 
constantly upregulated (Tran, O'Brien et al. 2010).  
It is evident further investigations to elucidate a marker or markers of malignant potential 
are required to aid detection of malignant and pre-malignant lesions, as well as to better 
predict the prognosis of individuals with HNSCC. With the advent of accessible gene 
sequence information and high throughput genetic methods, genetic alterations may act as 
such a marker.  
3.4 Cytokines 
Cytokines are a group of small, mainly secreted proteins that affect the behaviour of cells in 
a diverse number of ways. The binding of cytokines to specific cytokine receptors can 
induce a number of activities in the cell, such as growth, differentiation, or death (Janeway 
CA 1996). Although most cytokines have pleotrophic effects, some are generally considered 
pro-inflammatory, such as interferon-gamma (IFN-Ȗ), tumour necrosis factor-alpha (TNF-α) 
and interleukin-1beta (IL-1ȕ) (Dinarello CA 1997), whereas others are associated with anti-
inflammatory effects, such as transforming growth factor-beta-1 (TGF-ȕ1) (Ling EM 2002). 
Over the last 5 years or so, a considerable effort has been undertaken analysing the salivary 
proteome. There has been a very large number of non-redundant proteins recognised in 
saliva with one study (Scarano E 2010) reporting over 1400, while a further (Xiao H 2011) 
almost 2,000, reflecting the potency of salivary biomarker profiles in the identification and 
management of a range of diseases (Bandhakavi S 2009). Salivary biomarkers have the 
potential to serve as non-invasive, widely available screening tools that do not rely on the 
localization of a lesion for diagnosis. This advantage over other detection methods gives 
salivary biomarker screening the potential to identify patients with premalignant lesions.  
Of particular interest has been the use of salivary cytokine levels as markers of cell 
proliferation and oral cancer (Schapher M 2011) with the most studied cytokines including 
epidermal growth factor (EGF), interleukin 6 and 8, vascular endothelial growth factor 
(VEGF), interleukin 4 and 10, tumour necrosis factor (TNF) and endothelin. 
A large body of work has assess interleukin 6 (IL-6), a multifunctional cytokine that 
participates in the inflammatory and immune responses shown to directly promote the 
growth of certain types of cancer as well as being associated with an increased rate of 
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metastasis (St John MA 2004) (Brailo V, 2006 #143). Interestingly, IL-6 would appear to have 
different effects on different cell populations, stimulatory for some cell types, while 
inhibitory for others (Wang YF 2002) as well as demonstrable direct effect on cancer cells 
due to inactivation of the p53 tumour suppressor gene (Hodge DR 2005). Irrespective of the 
role of IL-6, there is an increasing body of evidence to support that there is higher level of 
IL-6 in saliva of patient with oral cancer as well as oral potentially malignant lesions, than in 
normal controls. In a recently trial of 29 consecutive patients being treated for oral cancer it 
was shown that these patients had much higher salivary concentration of IL-6 than in 
controls and that this concentration increased during the treatment period returning to 
baseline levels at discharge (Sato J 2010).  
Other studies however have assessed a panel of pro-inflammatory cytokines as makers of 
malignancy. In a recent study of levels of IL-1a, IL-6, IL-8, VEGF-a and TNF-a in saliva were 
measured using quantitative ELISA in a grop of 18 patinets with tongue SCC. These 
biomarkers were increased in patients with oral cancer, significantly increased in a sub-
group of patients with endophytic tongue cancer and IL-8 levels particularly shown to 
correlate with poor prognosis as well as controls who smoke and consumed alcohol daily 
(Korostoff A 2011). 
These findings indicate that salivary cytokine levels is very likely to provide useful 
information of epithelial behaviour and carcinogenesis and the potential of a panel of these 
cytokines being able to be used as a screening tool for oral cancer is currently underway, the 
results of which are eagerly awaited as this is likely to have a profound impact on the early 
detection of oral cancer and thus morbidity and mortality.  
3.5 Chemokines 
Chemokines are a superfamily of structurally related cytokines, which share an ability to 
chemotactically attract their target cells along a concentration gradient. It is through this 
ability that these molecules play an integral role in the migration of immune cells to areas of 
pathogen challenge. Chemokines also mediate the movements of cells to allow interactions 
between immune cells that are essential for mounting immune responses (Zlotnik A 2000).  
All chemokines are small proteins, ranging in weight from 6-14KDa. There are now over 40 
identified chemokines which can be classified into 4 main structural families, dependent 
upon the position of cysteine residues near the N-terminus. These families are the CC, CXC, 
C and CX3C, with the X denoting the number of amino acids between the cysteine residues 
(Olsen TS 2002). Nearly all chemokines are secreted from the site of production and they 
often bind with glycosaminoglycans (Hoogewerf AJ, Kuschert GS et al. 1997 Nov 4). It is 
thought that this is the method in which the chemokines form the concentration gradient 
that target cells migrate towards, as a higher concentration is formed on the connective 
tissue nearest the area of chemokine production.  
The function of chemokines can be subdivided into two main families; those that are 
induced after inflammatory stimuli, the inflammatory chemokines, and those produced 
constitutively in tissues, the homing chemokines (Kunkel EJ 2002). There appears to be some 
overlap between these chemokines as some of the inflammatory chemokines appear to be 
produced constitutively in some areas of the body (Izadpanah A 2001) and some of the 
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chemokines designated as homing chemokines can be upregulated by inflammatory stimuli 
(Morales J 1999)  .  
Although the detection of chemokine levels by enzyme-linked immunosorbent assay 
(ELISA) has become a sensitive and specific method to determine the chemokine profile in 
patient fluids, this does not fully represent the actual inflammatory conditions in vivo. 
Indeed, many chemokines are post-translationally modified by proteolytic cleavage, which 
can render an agonist more active, inactive or even convert the active chemokine into a 
receptor antagonist of the intact molecule (Struyf S 2003).  
A recent study analysed, using ELISA, the saliva of patients with oral cancer for the 
presence of both inflammatory chemokines (CXCL8, CXCL10 and CCL2) as well as 
homeostatic chemokines (CXCL4, CCL14 and CCL18) (Michiels K 2009). Patients with and 
without periodontitis were used as controls and it was found that H&N carcinomas give rise 
to a change in the chemokine composition of the oral fluid with a significant increase in 
CXCL8, CXCL10, and CCL14 before, but not after, therapy. However, the levels detectable 
by ELISA were very low and it is likely that more refined methods should indicate not only 
intact chemokines, but also those modified post-translationally. These authors conclude that 
it can be expected that specific truncated chemokines and the proteases involved are linked 
to a particular disease state and postulate that further proteomic analysis of biological fluids 
will help us to learn more about the pathogenesis of specific diseases and can provide 
solutions for new diagnostic and treatment options. 
4. Conclusion 
Oral cancer is a significant problem with low rates of mortality and an enormous impact on 
quality of life and morbidity. In the past this has been predominantly a disease of the elderly 
with known epidemiologic risk factors, however this appears to be changing. The principle 
recognized risk factor is smoking; however, there is growing evidence that the local effect of 
alcohol, most likely via its toxic metabolite acetaldehyde, may be increasing in importance. 
There is now evidence that alcohol containing mouthwash show similar oral acetaldehyde 
levels as recreational alcohol containing liquids. Further, these mouthwashes have been 
shown to have genotoxic effect in oral epithelial cells. Therefore be inadvisable for oral 
health care professionals to recommend the long-term use of alcohol-containing 
mouthwashes. 
Particular high-risk HPV sub-types are now known to be implicated in a large proportion of 
oro-pharyngeal cancers and these same sub-types are present in the oral cavity. It has been 
postulated that there is synergism of risk factors, such as smoking and alcohol consumption. 
As these previously under-recognized risk factors may be becoming of increasing important 
aetiological agents, there is therefore a need for the development and clinical validation of a 
simple salivary method for the assessment of risk of developing oral cancer that is not 
associated with smoking as this is likely to enhance the effectiveness of oral cancer screening 
services and improving oral cancer outcomes. Identifying a combination of salivary 
biomarkers that predict at- risk and cancerous states with sufficient sensitivity and 
specificity for widespread use will have a profound impact on improving the morbidity and 
mortality of the disease. 
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A number of cellular and molecular markers are currently under ongoing investigation to 
aid in the detection of early changes to aid in the detection of oral mucosal lesions with 
increased malignant potential. With the advent of accessible gene sequence information and 
high throughput genetic methods, genetic alterations may act as such a marker. 
Furthermore, there is evidence that salivary cytokine levels can provide useful information 
of oral epithelial behaviour and carcinogenesis and the potential of a panel of these 
cytokines being able to be used as a screening tool for oral cancer is currently underway, the 
results of which are eagerly awaited as this is likely to have a profound impact on the early 
detection of oral cancer and thus morbidity and mortality. Finally, further genomic and 
proteomic analysis of oral tissue, whether oral biological fluids or cells, will help us to learn 
more about the pathogenesis of oral cancer and it is anticipated that this will provide 
solutions for new diagnostic and treatment options. 
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